{"id":"W4413139122","doi":"10.1182/bloodadvances.2024015599","title":"New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Legend Biotech; Pharmacyclics; Eurostars; Genentech; National Institutes of Health; Juno Therapeutics; Astellas Pharma; Swedish Orphan Biovitrum; Omeros Corporation; BeiGene; Pfizer; Incyte; bluebird bio; Jazz Pharmaceuticals; National Cancer Institute; Servier; Gilead Sciences; Moffitt Cancer Center; Society for Immunotherapy of Cancer; Cidara Therapeutics; Celgene; Fred Hutchinson Cancer Research Center; Karyopharm Therapeutics; Memorial Sloan-Kettering Cancer Center; Massachusetts General Hospital; Amgen; Bristol-Myers Squibb","keywords":"Medicine; Comorbidity; Internal medicine; Hazard ratio; Lymphoma; Diabetes mellitus; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003737292,0.0002960639,0.0005480803,0.0001590127,0.0001362308,0.00004609204,0.0002253789,0.0001397854,0.001108741],"category_scores_gemma":[0.00006395172,0.0002310376,0.0001705984,0.000650824,0.00006917457,0.000140581,0.00005143179,0.0001830245,0.00002054808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007996023,"about_ca_system_score_gemma":0.0005374675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007815458,"about_ca_topic_score_gemma":0.0001754661,"domain_scores_codex":[0.9979939,0.0001096528,0.0002786284,0.0005030301,0.0004813092,0.0006335214],"domain_scores_gemma":[0.9987568,0.0003023364,0.000123356,0.0004267159,0.0002012345,0.000189611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01363789,0.009900228,0.7335166,0.0003627166,0.001249434,0.00007145196,0.0005205183,0.000005765432,0.1246917,0.00006350302,0.006232975,0.1097472],"study_design_scores_gemma":[0.05803588,0.002012405,0.1275369,0.0002398004,0.0001682274,0.000004419299,0.000252409,0.00005410076,0.2095122,0.0001670354,0.6015111,0.000505576],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973092,0.01315073,0.001407967,0.0004688652,0.0004231048,0.00163812,0.00009827484,0.000150774,0.009570167],"genre_scores_gemma":[0.9316506,0.004781974,0.001594145,0.0006722016,0.0003362775,0.0001982461,0.0001403919,0.00007917768,0.06054698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6059797,"threshold_uncertainty_score":0.9998044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01401590502790424,"score_gpt":0.2952427108687055,"score_spread":0.2812268058408013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}